Showing results (71-80 of 230) with videos related to
Sort By:
Pageof 23
Gynecologic Oncology|December 23, 2023
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregiversRachel A Pozzar, Jaclyn A Wall, Anna Tavormina, et al.Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.Gynecologic Oncology Reports|August 31, 2019
Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancerElizabeth K Lee, Zhenying Tan-Wasielewski, Ursula A Matulonis, et al.Future Oncology (London, England)|July 6, 2022
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic contextAntonio González-Martín, Ursula A Matulonis, Jacob Korach, et al.Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|July 5, 2005
The relationship between the Activities-specific Balance Confidence Scale and the Dynamic Gait Index in peripheral vestibular dysfunctionKristine Legters, Susan L Whitney, Rebecca Porter, et al.Clinical Chemistry|October 15, 2010
CA125 immune complexes in ovarian cancer patients with low CA125 concentrationsDaniel W Cramer, Dennis J O'Rourke, Allison F Vitonis, et al.Oncoimmunology|March 28, 2017
Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expressionBrooke E Howitt, Kyle C Strickland, Lynette M Sholl, et al.Gynecologic Oncology|June 2, 2009
Comparison of the quality of life of early and advanced stage ovarian cancer survivorsKristina L Mirabeau-Beale, Alice B Kornblith, Richard T Penson, et al.Gynecologic Oncology|June 16, 2004
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesRichard T Penson, Michael V Seiden, Annekathryn Goodman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancerStephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.Pageof 23